13 April 2024>: Articles
Successful Superficial Blood Sampling to Localize a Fibroblast Growth Factor-23-Producing Tumor
Challenging differential diagnosis, Unusual setting of medical care, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Junjiro Rikitake A , Kenji Ashida A* , Ayako Nagayama A , Yukihiro Inoguchi C , Nao Hasuzawa C , Masamichi Koganemaru B , Tetsuya Hamada B , Kanoko Moritaka B , Mutsuyuki Demiya B , Tomoki Sako B , Jun Akiba B , Koji Hiraoka B , Masatoshi Nomura ADOI: 10.12659/AJCR.943152
Am J Case Rep 2024; 25:e943152
Figure 6. Pathological findings. (A, B) Hematoxylin and eosin staining. The proliferation of spindle-shaped cells can be observed; however, no signs of malignancy were detected: (A) low magnification; and (B) high magnification. (C, D) Immunostaining with an anti-FGF-23 antibody (AdipoGen Life Sciences, CA, USA) shows scattered FGF-23-positive cells: (C) low magnification; and (D) high magnification. FGF-23 – fibroblast growth factor-23.